ADAI Library Library bookshelfMechManSeattle skyline
Library Home | ADAI Home

 

ADAI Bibliography # AD-120

Please consult your local public or college library to obtain these materials. The ADAI Library cannot provide copies except to University of Washington faculty, students and affiliates for research and educational purposes.

HIV INTERVENTIONS WITH DRUG USERS

Updated 7/24/96

  1. (no author). Integrating AIDS prevention and chemical dependency treatment. J Psychoactive Drugs 1989 Oct-Dec;21(4):361-442 (ADAI jl).

  2. (no author). Reducing HIV transmission in intravenous-drug users not in drug treatment - United States. MMWR 1990;39(31):529, 535-8 (ADAI rp 04410).

  3. (no author). Public policy statement on primary medical care for HIV infected patients in addiction treatment: American Society of Addiction Medicine. J Addict Dis 1995;14(3):129-30 (ADAI jl).

  4. (no author). Public policy statement on HIV testing of patients in addiction treatment facilities: American Society of Addiction Medicine. J Addict Dis 1995;14(3):131-3 (ADAI jl).

  5. Adams RA, Piercy FP, Jurich JA, Lewis RA. Components of a model adolescent AIDS/drug abuse prevention program: a Delphi study. Fam Relatations 1992;41:312-317 (ADAI rp 05540).

  6. Alcabes P, Vlahov D, Anthony JC. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? Br J Addict 1992 Jan;87(1):47-54 (ADAI jl).

  7. Aldrich MR. Creating a profession: training outreach workers for AIDS intervention among drug users. In: Trebach AS ; Zeese KB (eds.) THE GREAT ISSUES OF DRUG POLICY. Washington DC : Drug Policy Foundation, 1990, pp. 216-218 (ADAI bk) Call No: HV 5825 G84 1990.

  8. Allen DM, Onorato IM, Green TA. HIV infection in intravenous drug users entering drug treatment, United States, 1988 to 1989. Am J Public Health 1992;82(4):541-546 (ADAI rp 05346).

  9. American Medical Society on Alcoholism and Other Drug Dependencies. Guidelines for facilities. Treating chemically dependent patients at risk for AIDS or infected by HIV virus. New York : AMSAODD, 1987, 13 p. (ADAI rp 01734).

  10. Andersen MD, Smereck GA, Braunstein MS. LIGHT model: an effective intervention model to change high-risk AIDS behaviors among hard-to-reach urban drug users. Am J Drug Alcohol Abuse 1993;19(3):309-25 (ADAI jl).

  11. Anglin MD, Miller ML, Mantius K, Grella C. Enhanced methadone maintenance treatment: limiting the spread of HIV among high-risk Los Angeles narcotics addicts. In: Inciardi JA ; Tims FM ; Fletcher BW (eds.) INNOVATIVE APPROACHES IN THE TREATMENT OF DRUG ABUSE: PROGRAM MODELS AND STRATEGIES. Westport, CT : Greenwood Press, 1993, pp. 3-19 (ADAI bk) Call No: RC 564 I55 1993.

  12. Ashery R. S. TRAINING DRUG TREATMENT STAFF IN THE AGE OF AIDS: A FRONTLINE PERSPECTIVE. Rockville : National Institute on Drug Abuse. Div. of Applied Research. Community Research Branch, 1991, v, 36 p. (Books) Call No: RA 644 A25 T83 1991.

  13. Ashery RS. Issues in AIDS training for substance abuse workers. J Subst Abuse Treat 1992;9(1):15-9 (ADAI jl).

  14. Ashery RS. Nontraditional employees: indigenous outreach workers employed as AIDS educators for street addicts. J Community Psychol 1993;21:200-209 (ADAI rp 06151).

  15. Ashery RS, Davis H, Davis WH, Ross RI. Entry into treatment of IDUs based on the association of outreach workers with treatment programs. In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.386-395 (ADAI bk) Call No: RA 644 A25 H366 1993.

  16. Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark W, Hulley SB. HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 1994;271(7):515-518 (ADAI rp 06884).

  17. Bagasra O, Kajdacsy-Balla A, Lischner HW. Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions. Alcoholism (N Y) 1989 Oct;13(5):636-43 (ADAI jl).

  18. Baker A, Heather N, Wodak A. The application of self-control strategies to reducing HIV risk-taking behaviour in intravenous drug users. In: Heather N ; Miller WR ; Greeley J (eds.) SELF-CONTROL AND THE ADDICTIVE BEHAVIOURS. Botany, Australia: Maxwell MacMillan Publishing Australia, 1991, pp. 357-367 (ADAI bk) Call No: BF 632 S25 1991.

  19. Baker A, Heather N, Wodak A, Dixon J, Holt P. Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users. AIDS 1993;7:247-256 (ADAI rp 06052).

  20. Baker A, Kochan N, Dixon J, Heather N, Wodak A. Controlled evaluation of a brief intervention for HIV prevention among injecting drug users not in treatment. AIDS Care 1994;6(5):559-570 (ADAI rp 06856).

  21. Baker A, Kochan N, Dixon J, Wodak A, Heather N. Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia. Drug Alcohol Depend 1994 Jan;34(2):155-60 (ADAI jl).

  22. Baker A, Kochan N, Dixon J, Wodak A, Heather N. HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction 1995 Apr;90(4):545-54 (ADAI jl).

  23. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988;29:214-26 (ADAI rp 03485).

  24. Barth R. P., Pietrzak J., Remler M. (eds.) FAMILIES LIVING WITH DRUGS AND HIV : INTERVENTION AND TREATMENT STRATEGIES. New York : Guilford Press, 1993, xvi, 368 p. (Books) Call No: RJ 387 A25 F36 1993.

  25. Barth RP, Ramler M, Pietrzak J. Toward more effective and efficient programs for drug- and AIDS-affected families. In: Barth RP ; Pietrzak J ; Ramler M (eds.) FAMILIES LIVING WITH DRUGS AND HIV; INTERVENTION AND TREATMENT STRATEGIES. New York : Guilford Press, 1993, pp.337-353 (ADAI bk) Call No: RJ 387 A25 F36 1993.

  26. Batki SL. Treatment of intravenous drug users with AIDS: the role of methadone maintenance. J Psychoactive Drugs 1988 Apr-Jun;20(2):213-6 (ADAI jl).

  27. Batki SL, London J. Drug abuse treatment for HIV-infected patients. In: Sorensen JL ; Wermuth LA ; Gibson DR ; Choi KH ; Guydish JR ; Batki SL (eds.) PREVENTING AIDS IN DRUG USERS AND THEIR SEXUAL PARTNERS. New York : Guilford Press, 1991, pp. 77-98. (ADAI bk) Call No: RA 644 A25 P753 1991.

  28. Batki SL, Sorensen JL, Faltz B, Madover S. Psychiatric aspects of treatment of IV drug abusers with AIDS. Hosp Community Psychiatry 1988;39(4):439-41 (ADAI rp 02735).

  29. Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P. HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report. NIDA Res Monogr 1989;95:405-6 (ADAI bk) Call No: HV 5825 C617 1989.

  30. Bellis DJ. Reduction of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance. J Addict Dis 1993;12(1):7-23 (ADAI jl).

  31. Big D. Needle-exchange programmes reduce HIV transmission among people who inject illegal drugs. Int J Drug Policy 1995;6(4):222-225 (ADAI jl).

  32. Black JL, Dolan MP, Skinner JR, Shorey J, DeFord HA. Assessment of AIDS risk among treatment seeking drug abusers. American Psychological Assoc. annual meeting, New York, 1987, (ADAI rp 02160).

  33. Boatler JF, Knight K, Simpson DD. Assessment of an AIDS intervention program during drug abuse treatment. J Subst Abuse Treat 1994 Jul-Aug;11(4):367-72 (ADAI jl).

  34. Bocker FM. Methadone and AIDS: are methadone maintenance treatment programmes (MMTP's) apt to prevent HIV infections among intravenous drug users? Eur J Psychiatry 1992;6(4):197-206 (ADAI rp 05888).

  35. Bonito AJ, Bohlig EM, Dennis ML, Fairbank JA, Rachal JV. A comparison of AIDS intervention approaches for injection drug users: Street outreach versus drug treatment intake--are they hitting the same or different targets? In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.396-433 (ADAI bk) Call No: RA 644 A25 H366 1993.

  36. Booth R, Wiebel WW. Effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users. Am J Addict 1992;1(4):277-287 (ADAI jl).

  37. Boscarino JA, Avins AL, Woods WJ, Lindan CP, Hudes ES, Clark, W. Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: implications for prevention. J Stud Alcohol 1995 Nov;56(6):642-53 (ADAI jl).

  38. Broadhead RS, Fox KJ. Occupational health risks of harm reduction work: Combating AIDS among injection drug users. Adv Med Sociol 1993;3:123-142 (ADAI rp 06617).

  39. Broadhead RS, Heckathorn DD, Grund JC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS : Preliminary results of a peer-driven intervention. J Drug Issues 1995;25(3):531-564 (ADAI jl).

  40. Broadhead RS, Heckathorn DD, Grund JPC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS. Part I : Agency problems in traditional outreach interventions. Int J Drug Policy 1995;6(3):178-188 (ADAI jl).

  41. Broadhead RS, Heckathorn DD, Grund JC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS. Part II : Preliminary results. Int J Drug Policy 1995;6(4):274-288 (ADAI jl).

  42. Brown BS. AIDS and the provision of drug user treatment. Int J Addict 1990-91;25(12A):1503-14 (ADAI jl).

  43. Brown BS, Beschner GM. AIDS and HIV infection -- implications for drug abuse treatment. J Drug Issues 1989;19(1):141-62 (ADAI jl).

  44. Brown BS, Needle RH. Modifying the process of treatment to meet the threat of AIDS. Int J Addict 1994 Nov;29(13):1739-52 (ADAI jl).

  45. Brown LS Jr. Black intravenous drug users: prospects for intervening in the transmission of human immunodeficiency virus infection. NIDA Res Monogr 1990;93:53-67. (ADAI bk) Call No: RA 644 A25 A255 1990.

  46. Brown LS Jr. The impact of AIDS on drug abuse treatment. NIDA Res Monogr 1991;106:385-93 (ADAI bk) Call No: RC 566 I45 1991.

  47. Brown LS Jr, Phillips RY, Nurco D, Primm B, Battjes R, Nemoto T. HIV infection in intravenous drug abusers (IVDAs) in NYC drug treatment clinics: 1985-1989. NIDA Res Monogr 1991;105:478-9 (ADAI bk) Call No: HV 5825 C617 1990.

  48. Cabaj RP. AIDS and chemical dependency: special issues and treatment barriers for gay and bisexual men. J Psychoactive Drugs 1989 Oct-Dec;21(4):387-93 (ADAI jl).

  49. Calsyn DA, Saxon AJ, Freeman G Jr, Whittaker S. Effects of education on high risk HIV transmission behaviors. NIDA Res Monogr 1991;105:482-3 (ADAI bk) Call No: HV 5825 C617 1990.

  50. Canadian Public Health Association. AIDS Program. Needle exchange programs in Canada. Savoir Faire: HIV Prev News 1994;1:1-15 (ADAI rp 06819).

  51. Capone CT, Melchionda R, DeRovira N, Katowsky K, Condren R, Peterson M. A cognitive-existential analysis of counselor responses to HIV-positive substance misusers in an outpatient methadone program and a residential therapeutic community. Int J Addict 1992 May;27(5):587-611 (ADAI jl).

  52. Carballo-Dieguez A, Sahs J, Goetz R, el Sadr W, Sorell S, Gorman J. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. Am J Drug Alcohol Abuse 1994 Aug;20(3):317-29 (ADAI jl).

  53. Carroll JFX. Working with drug dependent residents with AIDS / ARC in a therapeutic community. Alcohol Treat Q 1988;5(4):163-89 (ADAI jl).

  54. Chachkes E, Kaufer S, Primack S, Ullah E. Countertransference in professionals working with chemically dependent clients with HIV. J Chem Depend Treat 1991;4(2):159-70 (ADAI jl).

  55. Chitwood DD, Comerford M, Khoury EL, Vogel JA. Behavior changes of intravenous drug users after an intervention program. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 449-55 (ADAI bk) Call No: RA 644 A25 C36 1991.

  56. Chitwood DD, Comerford M, Trapido EJ. Strategies for enhancing existing studies of the natural history of HIV-1 infection among drug users. NIDA Res Monogr 1991;109:9-28 (ADAI bk) Call No: RA 644 A25 L65 1991.

  57. Chitwood DD, Rivers JR, Comerford M, McBride DC. A comparison of HIV related risk behaviors of street recruited and treatment program recruited injection drug users. Drugs Society 1993;7(3/4):53-63 (ADAI jl).

  58. Chu A, Brown LS, Banks S, Nemoto T, Primm BJ. Intravenous heroin use: its association with HIV infection in patients in methadone treatment. NIDA Res Monogr 1989;95:447-8 (ADAI bk) Call No: HV 5825 C617 1989.

  59. Clark HW, Washburn P. Testing for human immunodeficiency virus in substance abuse treatment. J Psychoactive Drugs 1988 Apr-Jun;20(2):203-11 (ADAI jl).

  60. Clark SC. An AIDS primer for helping professionals and educators. Edmonton : Alberta Alcohol and Drug Abuse Commission, 1988, 28 p. (ADAI rp 03169).

  61. Clatts MC. Ethnography and AIDS intervention in New York City: the use of life history as a research strategy. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 225-33 (ADAI bk) Call No: RA 644 A25 C36 1991.

  62. Coleman RM, Curtis D, Feinmann C. Perception of risk of HIV infection by injecting drug users and effects on medical clinic attendance. Br J Addict 1988 Nov;83(11):1325-9 (ADAI jl).

  63. Compton WM, Lamb RJ, Fletcher BW. Results of the NIDA treatment demonstration grants' cocaine workgroup: characteristics of cocaine users and HIV risk behaviors. Drug Alcohol Depend 1995 Jan;37(1):1-6 (ADAI jl).

  64. Connors MM, Lewis BF, Russo JP, Baker LA. Drug treatment staff attitudes toward AIDS and workplace transmission of HIV: a survey and follow-up--Spectrum House, Inc. J Subst Abuse Treat 1991;8(4):297-302 (ADAI jl).

  65. Cooley PC, Hamill DN, Reade-Christopher SJ, Liner EC, van der, Horst CM. How can results of longitudinal studies help mathematicians model the HIV epidemic among intravenous drug abusers and the general population? NIDA Res Monogr 1991;109:125-44 (ADAI bk) Call No: RA 644 A25 L65 1991.

  66. Cottler LB, Compton WM, Price RK, Shillington AM, Claverie DJ, Works JE, Mager DE, Sharma D, Miller O. St. Louis's efforts to reduce the spread of AIDS. In: Inciardi JA ; Tims FM ; Fletcher BW (eds.) INNOVATIVE APPROACHES IN THE TREATMENT OF DRUG ABUSE: PROGRAM MODELS AND STRATEGIES. Westport, CT : Greenwood Press, 1993, pp. 205-218 (ADAI bk) Call No: RC 564 I55 1993.

  67. Curran JW, Scheckel LW, Millstein RA. The role of bleach in human immunodeficiency virus (HIV) prevention programs for injecting drug users (IDUs). HIV/AIDS Prev Bull 1993, 8 p. (ADAI rp 05799).

  68. Darke S, Baker A, Dixon J, Wodak A, Heather N. Drug use and HIV risk-taking behaviour among clients in methadone maintenance treatment. Drug Alcohol Depend 1992 Feb;29(3):263-8 (ADAI jl).

  69. Davis I. What drug treatment professionals need to know about medical aspects of HIV illness. J Chem Depend Treat 1991;4(2):17-30 (ADAI jl).

  70. de Jong WM. AIDS and self-organization of drug users in the Netherlands. In: Platt JJ ; Kaplan CD ; McKim PJ (eds.) THE EFFECTIVENESS OF DRUG ABUSE TREATMENT. Malabar, FL : Krieger Publishing Co., 1990, pp. 303-13. (ADAI bk) Call No: RC 566 E33 1990.

  71. DePhilippis D, Metzger DS, Woody GE, Navaline HA. Attitudes toward mandatory human immunodeficiency virus testing and contact tracing. A survey of intravenous drug users in treatment. J Subst Abuse Treat 1992;9(1):39-42 (ADAI jl).

  72. Deren S, Beardsley M, Tortu S, Davis R, Clatts M. Behavior change strategies for women at high risk for HIV. Drugs Society 1993;7(3/4):119-128 (ADAI jl).

  73. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict 1992 Mar;87(3):493-8 (ADAI jl).

  74. Des Jarlais DC, Padian NS, Winkelstein W. Targeted HIV-prevention programs. NEJM 1994;331(21):1451-1453 (ADAI rp 06730).

  75. Des Jarlis DC. Stages in the response of the drug abuse treatment system to the AIDS epidemic in New York City. J Drug Issues 1990;20(2):335-47 (ADAI jl).

  76. Diaz T, Chu SY, Byers RH, Hersh BS, Conti L, Rietmeijer CA, Mokotoff E, Fann A, Boyd D, Iglesias L, Checko PJ, Frederick M, Hermann P, Herr M, Samuel MC. The types of drugs used by HIV-infected injection drug users in a multistate surveillance projct; Implications for intervention. Am J Public Health 1994;84:1971-1975 (ADAI rp 06821).

  77. Downey AM, Davis WH, Davis H, Stackhouse T, Royster F. Preliminary findings for the AIDS targeted outreach model to intravenous drug users in three northeastern methadone programs. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 419-33 (ADAI bk) Call No: RA 644 A25 C36 1991.

  78. English A. Pediatric HIV infection and perinatal drug or alcohol exposure: legal issues and legal advocacy. In: Barth RP ; Pietrzak J ; Ramler M (eds.) FAMILIES LIVING WITH DRUGS AND HIV; INTERVENTION AND TREATMENT STRATEGIES. New York : Guilford Press, 1993, pp.299-336 (ADAI bk) Call No: RJ 387 A25 F36 1993.

  79. Erickson JR, Stevens S, Estrada AL, Glider P. Grounding intervention aimed at AIDS risk reduction in models of prevention. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 202-10 (ADAI bk) Call No: RA 644 A25 C36 1991.

  80. Ewing H, Foran M. The role of prenatal care services in assisting families affected by drugs, alcohol, and AIDS. In: Barth RP ; Pietrzak J ; Ramler M (eds.) FAMILIES LIVING WITH DRUGS AND HIV; INTERVENTION AND TREATMENT STRATEGIES. New York : Guilford Press, 1993, pp.82-115 (ADAI bk) Call No: RJ 387 A25 F36 1993.

  81. Faith RE, Plotnikoff NP, Murgo AJ. Effects of opiates and neuropeptides on immune functions. NIDA Res Monogr Ser 1984;54:300-11. (ADAI bk) Call No: QP 951 E5 M33 1984.

  82. Faltz BG, Madover S. Treatment of substance abuse in patients with HIV infection. Adv Alcohol Subst Abuse 1987;7(2):143-57 (ADAI jl).

  83. Farnham PG, Gorsky RD, Holtgrave DR, Jones WK, Guinan ME. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Rep 1996 Jan-Feb;111(1):44-53; discussion 54 (ADAI jl).

  84. Feldman HW, Biernacki P, MidCity Consortium to Combat AIDS. The ethnography of needle sharing among intravenous drug users and implications for public policies and intervention strategies. Technical Review Meeting on "Needle Sharing Among Intravenous Drug Abusers", May 18-19 1987, Bethesda MD, 12 p. (ADAI rp 00173).

  85. Ferrando SJ, Batki SL. HIV-infected intravenous drug users in methadone maintenance treatment: clinical problems and their management. J Psychoactive Drugs 1991 Apr-Jun;23(2):217-24 (ADAI jl).

  86. Finlinson HA, Robles RR, Colon HM, Page JB. Recruiting and retaining out-of-treatment injecting drug users in the Puerto Rico AIDS prevention project. Human Organization 1993;52(2):169-175 (ADAI rp 06030).

  87. Finnegan L, Selwyn P. Chemically dependent women, their children, and AIDS (workshop). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 47-51. (ADAI bk) Call No: RA 644 A25 K33 1988.

  88. Fischer G, Stein JB. HIV disease and substance abuse: training treatment professionals. Subst Abuse 1992;13(1):33-36 (ADAI jl).

  89. Fisher K, Selwyn P. Update in management strategies for persons with HIV spectrum disease (workshop). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 27-32. (ADAI bk) Call No: RA 644 A25 K33 1988.

  90. Freeman G, Fullwood PC. Community organizing as a primary intervention to reach IV drug users and the sexual partners of IV drug users. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 333-41 (ADAI bk) Call No: RA 644 A25 C36 1991.

  91. French J. F., Rodriguez G. M., Freeman R. C., Alexander R., Finn P. EVALUATION OF AN AIDS OUTREACH AND PREVENTION PROGRAM FOR INJECTION DRUG USERS NOT IN TREATMENT AND THEIR SEXUAL PARTNERS; THE PATERSON (NEW JERSEY) HEALTH BEHAVIOR PROJECT: DRAFT FINAL REPORT. n.l. : New Jersey State Department of Health, 1992, v, 99 p. (Books) Call No: RA 644 A25 F72 1992.

  92. French JF, Rosen MJ, Freeman RC, Rodriguez G. Injection drug users and self-help groups. In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.374-385 (ADAI bk) Call No: RA 644 A25 H366 1993.

  93. Friedman SR, de Jong WM, Des Jarlais DC. Organizing intravenous drug users for AIDS prevention. In: Platt JJ ; Kaplan CD ; McKim PJ (eds.) THE EFFECTIVENESS OF DRUG ABUSE TREATMENT. Malabar, FL : Krieger Publishing Co., 1990, pp. 315-30. (ADAI bk) Call No: RC 566 E33 1990.

  94. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol 1995;142(8):846-874 (ADAI rp 08252).

  95. Friedman SR, Neaigus A, Des Jarlais DC, Sotheran JL, Woods J, Sufian M, Stepherson B, Sterk C. Social intervention against AIDS among injecting drug users. Br J Addict 1992 Mar;87(3):393-404 (ADAI jl).

  96. Fugelstad A, Rajs J, Bottiger M, Gerhardsson de Verdier M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction 1995 May;90(5):711-6 (ADAI jl).

  97. Galea RP, Lewis BF, Baker LA. A model for implementing AIDS education in a drug abuse treatment setting. Hosp Community Psychiatry 1988;39(8):886-8 (ADAI rp 03296).

  98. Gasch H, Poulson DM, Fullilove RE, Fullilove MT. Shaping AIDS education and prevention programs for African Americans amidst community decline. J Negro Educ 1991;60(1):85-96 (ADAI rp 04678).

  99. Gillman C. AIDS: we have no strategy. No program. No policy. In: Trebach AS ; Zeese KB (eds.) DRUG PROHIBITION AND THE CONSCIENCE OF NATIONS. Washington, D.C. : The Drug Policy Foundation, 1990, pp. 129-133 (ADAI bk) Call No: HV 5825 D784 1990.

  100. Greene D, Falz B. Chemical dependency and relapse in gay men with HIV infection: issues and treatment. J Chem Depend Treat 1991;4(2):79-90 (ADAI jl).

  101. Greif GL, Price C. A community-based support group for HIV positive i.v. drug abusers: the HERO program. J Subst Abuse Treat 1988;5(4):263-6 (ADAI jl).

  102. Grief GL, Porembski E. Significant others of i.v. drug abusers with AIDS: new challenges for drug treatment programs. J Subst Abuse Treat 1987;4(3-4):151-5 (ADAI jl).

  103. Griffin R, Ryder B, Turner C. Effective techniques for outreach to intravenous drug users and sexual partners to combat AIDS. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 34-9 (ADAI bk) Call No: RA 644 A25 C36 1991.

  104. Gross M, DeJong W, Lamb D, Enos T, Mason T, Weitzman E. Drugs and AIDS--reaching for help: a videotape on AIDS and drug abuse prevention for criminal justice populations. J Drug Educ 1994;24(1):1-20 (ADAI jl).

  105. Grund JC, Stern LS, Kaplan CD, Adriaans NFP, Drucker E. Drug use contexts and HIV consequences: The effects of drug policy on patters of everyday drug use in Rotterdam and the Bronx. In: Langenbucher JW ; McCrady BS ; Frankenstein W ; Nathan PE (eds.) ANNUAL REVIEW OF ADDICTIONS RESEARCH AND TREATMENT, Vol. 3. Tarrytown, NY : Pergamon Press, 1994, pp.343-355 (ADAI bk) Call No: RC 533 A55 v.3.

  106. Grund JP, Stern LS, Kaplan CD, Adriaans NF, Drucker E. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. Br J Addict 1992 Mar;87(3):381-92 (ADAI jl).

  107. Guydish J, Temoshok L, Dilley J, Rinaldi J. Evaluation of a hospital based substance abuse intervention and referral service for HIV affected patients. Gen Hosp Psychiatry 1990;12:1-7 (ADAI rp 05121).

  108. Hagan H. Risk for human immunodeficiency virus and hepatitis B virus in users of the Tacoma Syringe Exchange Program. In: National Research Council and Institute of Medicine. WORKSHOP ON NEEDLE EXCHANGE AND BLEACH DISTRIBUTION PROGRAMS; PROCEEDINGS. Washington DC : National Academy Press, 1994, pp.24-34 (ADAI bk) Call No: RA 644 A25 N285 1994.

  109. Harrold LN. Intervention strategies for sexual partners at Proyecto Companeros. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 273-8 (ADAI bk) Call No: RA 644 A25 C36 1991.

  110. Hartgers C, Buning EC, van Saten GW, Verster AD, Coutinho RA. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS 1989;3:571-76 (ADAI rp 03975).

  111. Hawthorne W, Siegel L. Should there be HIV testing in chemical dependency treatment programs? Adv Alcohol Subst Abuse 1987;7(2):15-9 (ADAI jl).

  112. Hochhauser M. Health planning for chemically dependent AIDS/ARC patients (workshop). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 78-82 (ADAI bk) Call No: RA 644 A25 K33 1988.

  113. Holtgrave DR, Qualls NL, Curran JW, Valdiserri RO, Guinan ME, Parra WC. An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Rep 1995 Mar-Apr;110(2):134-46 (ADAI jl).

  114. Howell EF, Niven RG. The argument for HIV-antibody testing in chemical dependence treatment programs. J Psychoactive Drugs 1989 Oct-Dec;21(4):415-7 (ADAI jl).

  115. Huebert K, James D. High-risk behaviors for transmission of HIV among clients in treatment for substance abuse. J Drug Issues 1992;22(4):885-901 (ADAI jl).

  116. Iguchi MY, Platt JJ, French J, Baxter RC, Kushner H, Lidz VM, Bux DA, Rosen M, Musikoff H. Correlates of HIV seropositivity among injection drug users not in treatment. J Drug Issues 1992;22(4):849-866 (ADAI jl).

  117. Iguchi MY, Rosen M, Musikoff H, Kushner H, French J, Baxter, R, Lidz V, Platt JJ, Grant C. Predictors of HIV seropositivity in Newark and Jersey City i.v. drug users not currently enrolled in treatment. NIDA Res Monogr 1991;105:473-4 (ADAI bk) Call No: HV 5825 C617 1990.

  118. Imhof J, Hirsch R, Terenzi R. AIDS and the substance abuse treatment clinician [editorial] J Subst Abuse Treat 1985;2(3):137 (ADAI jl).

  119. Institute of Medicine. CONFRONTING AIDS: DIRECTIONS FOR PUBLIC HEALTH, HEALTH CARE, AND RESEARCH. Washington DC : National Academy Press, 1986, xvi, 374p. (Books) Call No: RA 644 A25 I57 1986.

  120. Jackson J, Smith D, Karan L. Integrating AIDS education and treatment with chemical dependency treatment (plenary session). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 62-73. (ADAI bk) Call No: RA 644 A25 K33 1988.

  121. Jackson JF, Rotkiewicz LG, Baxter RC. The role of drug abuse treatment programs in AIDS prevention and education programs for intravenous drug users: the New Jersey experience. NIDA Res Monogr 1990;93:167-86. (ADAI bk) Call No: RA 644 A25 A255 1990.

  122. Jackson JF, Rotkiewicz LG, Quinones MA, Passannante MR. A coupon program--drug treatment and AIDS education. Int J Addict 1989 Nov;24(11):1035-51 (ADAI jl).

  123. Jang M, Forst M, Moore M. AIDS education and prevention programs for intravenous drug users: the California experience. J Drug Educ 1990;20(1):1-13 (ADAI jl).

  124. Joseph H, Springer E. Methadone maintenance treatment and the AIDS epidemic. In: Platt JJ ; Kaplan CD ; McKim PJ (eds.) THE EFFECTIVENESS OF DRUG ABUSE TREATMENT. Malabar, FL : Krieger Publishing Co., 1990, pp. 261-74. (ADAI bk) Call No: RC 566 E33 1990.

  125. Joseph SC. AIDS and adolescence: a challenge to both treatment and prevention. In Rogers DE ; Ginzberg E (eds.) ADOLESCENTS AT RISK; MEDICAL AND SOCIAL PERSPECTIVES. San Francisco : Westview Press, 1992, pp. 96-103 (ADAI bk) Call No: RJ 503 A465 1992.

  126. Kaplan EH, Abramson PR. So what if the program ain't perfect? A mathematical model of AIDS education. Eval Rev 1989;13(2):107-122 (ADAI rp 03456).

  127. Karan LD. AIDS prevention and chemical dependence treatment needs of women and their children. J Psychoactive Drugs 1989 Oct-Dec;21(4):395-9 (ADAI jl).

  128. Karim QA, Karim SS, Soldan K, Zondi M. Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers [see comments] Am J Public Health 1995 Nov;85(11):1521-5 (ADAI jl).

  129. Kleyn J. E., Nyrop K., Simpson E. E. COMMUNITY ORGANIZING AS AN AIDS PREVENTION STRATEGY FOR INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS: SEATTLE'S EXPERIENCE. Seattle : Alcohol and Drug Abuse Institute, 1992. (Books) Call No: RA 644 A25 K53 1992.

  130. Kleyn J. E., Simpson E. E., Nyrop K., Clay C., Snyder N., McGough J. COMMUNITY HEALTH OUTREACH WORK AS AN AIDS PREVENTION STRATEGY: SEATTLE'S EXPERIENCE. Seattle : Alcohol and Drug Abuse Institute, 1992, viii, 41 p. (Books) Call No: RA 644 A25 K53 1992.

  131. Kotarba JA, Johnson J, Williams M. Health-care safety networks among adolescent intravenous drug users: implications for AIDS intervention. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 241-48 (ADAI bk) Call No: RA 644 A25 C36 1991.

  132. Kreek MJ. The role of methadone in the prevention and treatment of AIDS (workshop). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 33-4. (ADAI bk) Call No: RA 644 A25 K33 1988.

  133. Kroliczak A. Preliminary findings regarding AIDS intervention among Hispanics in the Southwest United States. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 389-401 (ADAI bk) Call No: RA 644 A25 C36 1991.

  134. Lampinen TM. Cost-effectiveness of drug abuse treatment for primary prevention of acquired immunodeficiency syndrome: epidemiologic considerations. NIDA Res Monogr 1991;113:114-28 (ADAI bk) Call No: RC 564 E375 1991.

  135. Lazzarin A, Mella L, Trombini M, Uberti-Foppa C, Franzetti F, Mazzoni G, Galli M. Immunological status in heroin addicts: effects of methadone maintenance treatment. Drug Alcohol Depend 1984 Mar;13(2):117-23 (ADAI jl).

  136. Leukefeld CG, Battjes RJ. Intravenous drug use and AIDS: community approaches to social work revisited. In: Freeman EM (ed.) THE ADDICTION PROCESS: EFFECTIVE SOCIAL WORK APPROACHES. New York : Longman, 1992. pp. 123-135 (ADAI bk) Call No: RC 533 A32 1992.

  137. Leukefeld CG, Battjes RJ, Pickens RW. AIDS prevention: criminal justice involvement of intravenous drug abusers entering methadone treatment. J Drug Issues 1991;21(4):673-83 (ADAI jl).

  138. Levallois C, Rouahi N, Balmes JL, Mani JC. Effects of ethanol in vitro on some parameters of the immune response. Drug Alcohol Depend 1989 Dec;24(3):239-44 (ADAI jl).

  139. Liebman J, Knezek LD, Coughey K, Hua S. Injection drug users, drug treatment, and HIV risk behavior. In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.355-373 (ADAI bk) Call No: RA 644 A25 H366 1993.

  140. Liebman J, Mulia N. An office-based AIDS prevention program for high risk drug users. Drugs Society 1993;7(3/4):205-223 (ADAI jl).

  141. Liebman J, Sepulveda-Irene B. Effectiveness of street outreach as an AIDS-prevention strategy for IV drug users, their sexual partners, and prostitutes in Philadelphia. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 40-6 (ADAI bk) Call No: RA 644 A25 C36 1991.

  142. Longshore D, Hsieh SC, Anglin MD. Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners. Int J Addict 1994 Apr;29(6):741-57 (ADAI jl).

  143. Lurie P, Chen D. A review of programs in North America. [needle exchange] In: Stryker J ; Smith M (eds.) DIMENSIONS OF HIV PREVENTION: NEEDLE EXCHANGE. Menlo Park, CA : Henry J. Kaiser Family Fdn., 1993, pp. 11-33 (ADAI bk) Call No: RA 644 A25 D25 1993.

  144. MacNair R, Elliott TR, Yoder B. AIDS prevention groups as persuasive appeals: effects on attitudes about precautionary behaviors among persons in substance abuse treatment. Small Group Res 1991;22(3):301-19 (ADAI rp 04905).

  145. Magura S, Siddiqi Q, Shapiro J, Grossman JI, Lipton DS, Marion IJ, Weisenfeld L, Amann KR, Koger J. Outcomes of an AIDS prevention program for methadone patients. Int J Addict 1991 Jun;26(6):629-55 (ADAI jl).

  146. Malow RM, Corrigan SA, Pena JM, Calkins AM, Bannister TM. Effectiveness of a psychoeducational approach to HIV risk behavior reduction. Psychol Addict Behav 1992;6(2):120-125 (ADAI jl).

  147. Marietta CA, Jerrells TR, Meagher RC, Karanian JW, Weight FF, Eckardt MJ. Effects of long-term ethanol inhalation on the immune and hematopoietic systems of the rat. Alcoholism (NY) 1988 Apr;12(2):211-4 (ADAI jl).

  148. McCoy CB, Chitwood DD, Khoury EL, Miles CE. The implementation of an experimental research design in the evaluation of an intervention to prevent AIDS among IV drug users. J Drug Issues 1990;20(2):215-222 (ADAI jl).

  149. McCoy CB, Trapido EJ, Lewis N, Khoury EL. Belle Glade, Florida: the national AIDS demonstration research (NADR) project's only rural AIDS-intervention program. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 295-307 (ADAI bk) Call No: RA 644 A25 C36 1991.

  150. McCoy HV, Dodds SE, Nolan C. AIDS intervention design for program evaluation: the Miami community outreach project. J Drug Issues 1990;20(2):223-243 (ADAI jl).

  151. McCusker J, Bigelow C, Frost R, Hindin R, Vickers-Lahti M, Zorn M. The relationships of HIV status and HIV risky behavior with readiness for treatment. Drug Alcohol Depend 1994 Jan;34(2):129-38 (ADAI jl).

  152. McCusker J, Bigelow C, Luippold R, Zorn M, Lewis BF. Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am J Drug Alcohol Abuse 1995 Feb;21(1):1-16 (ADAI jl).

  153. McCusker J, Goldstein R, Bigelow C, Zorn M. Psychiatric status and HIV risk reduction among residential drug abuse treatment clients. Addiction 1995;90(10):1377-1387 (ADAI jl).

  154. McCusker J, Stoddard AM, Koblin BA, Sullivan J, Lewis BF, Sereti SM. Time trends in high-risk injection practices in a multi-site study in Massachusetts: effects of enrollment site and residence. AIDS Educ Prev 1992;4(2):108-119 (ADAI rp 05382).

  155. McCusker J, Stoddard AM, Zapka JG, Morrison CS, Zorn M, Lewis BF. AIDS education for drug abusers: evaluation of short-term effectiveness. Am J Public Health 1992;82(4):533-540 (ADAI rp 05333).

  156. McCusker J, Willis G, McDonald M, Lewis BF, Sereti SM, Feldman ZT. Admissions of injection drug users to drug abuse treatment following HIV counseling and testing. Public Health Rep 1994 Mar-Apr;109(2):212-8 (ADAI jl).

  157. McLachlan C, Crofts N, Wodak A, Crowe S. The effects of methadone on immune function among injecting drug users: a review. Addiction 1993 Feb;88(2):257-63 (ADAI jl).

  158. Mersky SA. Testing for human immunodeficiency virus in chemical dependence treatment programs. J Psychoactive Drugs 1989 Oct-Dec;21(4):407-13 (ADAI jl).

  159. Millson M. Toronto's HIV prevention program for injection drug users: Trends in risk behaviour and HIV seroprevalence over two and a half years. In: National Research Council and Institute of Medicine. WORKSHOP ON NEEDLE EXCHANGE AND BLEACH DISTRIBUTION PROGRAMS; PROCEEDINGS. Washington DC : National Academy Press, 1994, pp.78-82 (ADAI bk) Call No: RA 644 A25 N285 1994.

  160. Millson M, Coates R, Devenyi P, Franklin T, Rankin J. AIDS-related knowledge, attitudes and behaviour in injection drug users attending a Toronto treatment facility. Can J Public Health 1990;81:46-52 (ADAI rp 04123).

  161. Millson M, Hankins C. Evaluation of human immunodeficiency virus prevention programs for injection drug users in Canada. In: National Research Council and Institute of Medicine. WORKSHOP ON NEEDLE EXCHANGE AND BLEACH DISTRIBUTION PROGRAMS; PROCEEDINGS. Washington DC : National Academy Press, 1994, pp.72-77 (ADAI bk) Call No: RA 644 A25 N285 1994.

  162. Moini S. AIDS and female partners of IV drug users: selected outreach strategies, accomplishments, and preliminary data from one project. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 18-25 (ADAI bk) Call No: RA 644 A25 C36 1991.

  163. Mondanaro J. CHEMICALLY DEPENDENT WOMEN: ASSESSMENT AND TREATMENT. Lexington, MA : Lexington Books, 1989, xvi, 170 p. (Books) Call No: HV 5137 M66 1989.

  164. Mondanaro J. Community-based AIDS prevention interventions: special issues of women intravenous drug users. NIDA Res Monogr 1990;93:68-82. (ADAI bk) Call No: RA 644 A25 A255 1990.

  165. Mondanaro J. Strategies for AIDS prevention: motivating health behavior in drug dependent women. J Psychoactive Drugs 1987 Apr-Jun;19(2):143-9 (ADAI jl).

  166. Myers T. Canadian pharmacies' resonse to HIV and harm reduction strategies: A report from the National Survey on Community Pharmacies and HIV/AIDS Prevention. In: National Research Council and Institute of Medicine. WORKSHOP ON NEEDLE EXCHANGE AND BLEACH DISTRIBUTION PROGRAMS; PROCEEDINGS. Washington DC : National Academy Press, 1994, pp.135-151 (ADAI bk) Call No: RA 644 A25 N285 1994.

  167. Nathan JA, Karan LD. Substance abuse treatment modalities in the age of HIV spectrum disease. J Psychoactive Drugs 1989 Oct-Dec;21(4):423-9 (ADAI jl).

  168. National Conference on Preventing and Treating Alcohol and Other, Drug Abuse H. I. SECOND NATIONAL CONFERENCE ON PREVENTING AND TREATING ALCOHOL AND OTHER DRUG ABUSE, HIV INFECTION, AND AIDS IN BLACK COMMUNITIES : FROM ADVOCACY TO ACTION. Rockville : Center for Substance Abuse Prevention, 1993, x, 268 p. (Books) Call No: HV 5825 O44 v.13.

  169. Neaigus A, Sufian M, Friedman SR, Goldsmith DS, Stepherson B, Mota P, Pascal J, Des Jarlais DC. Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prev 1990;2(4):253-271 (ADAI rp 04816).

  170. Nelson FL, Kabacy M. Evaluation of an AIDS prevention education program for health service providers working with IV drug users. J Subst Abuse 1989;1(4):467-70 (ADAI jl).

  171. Nemoto T, Foster K Sr, Brown LS Jr. Effect of psychological factors on risk behavior of human immunodeficiency virus (HIV) infection among intravenous drug users (IVDUs). Int J Addict 1991 Apr;26(4):441-56 (ADAI jl).

  172. Newman RG. AIDS and intravenous drug abuse--what about treatment? [letter] Br J Addict 1987 Jan;82(1):101-2 (ADAI jl).

  173. Newmeyer JA. Why bleach? Development of a strategy to combat HIV contagion among San Francisco intravenous drug users. NIDA Res Monogr Ser 1988;80:151-9 (ADAI bk) Call No: RA 644 A25 N44 1988.

  174. Orr DA, Pinto PF. The clinical management of HIV-related dementia and other memory disorders in the residential drug treatment environment. J Subst Abuse Treat 1993 Nov-Dec;10(6):505-11 (ADAI jl).

  175. Pascal CB. Selected legal issues about AIDS for drug abuse treatment programs. J Psychoactive Drugs 1987 Jan-Mar;19(1):1-12 (ADAI jl).

  176. Passannante MR, Wells DV, Quinones MA, Jackson JF, Rotkiewicz, LG. AIDS education in drug user treatment programs. Int J Addict 1991 May;26(5):577-94 (ADAI jl).

  177. Paul JP, Stall R, Davis F. Sexual risk for HIV transmission among gay/bisexual men in substance-abuse treatment. AIDS Educ Prev 1993;5(1):11-24 (ADAI rp 05929).

  178. Payne SF, Rutherford GW, Lemp GF, Clevenger AC. Effect of the revised AIDS case definition on AIDS reporting in San Francisco: evidence of increased reporting in intravenous drug users. AIDS 1990;4:335-9 (ADAI rp 04320).

  179. Persico AM, Di Giannantonio M, Tempesta E. A prospective assessment of opiate addiction treatment protocols for inpatients with HIV-related syndromes. Drug Alcohol Depend 1991 Jan;27(1):79-86 (ADAI jl).

  180. Petosa R. Designing effective AIDS prevention programs for adolescents. In: Lawson GW ; Lawson AW (eds.) ADOLESCENT SUBSTANCE ABUSE: ETIOLOGY, TREATMENT, AND PREVENTION. Gaithersburg, MD : Aspen Publishers, 1992. pp.463-480 (ADAI bk) Call No: RJ 506 D78 A364 1992.

  181. Pohl M, Ryan C. Counseling the HIV and chemically dependent patient (workshop). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 22-6. (ADAI bk) Call No: RA 644 A25 K33 1988.

  182. Pohl MI. Counseling patients in chemical dependence treatment programs about AIDS. J Psychoactive Drugs 1988 Apr-Jun;20(2):223-6 (ADAI jl).

  183. Postol LP. Handicap discrimination considerations in treating the impaired worker : drugs, alcohol, pregnancy, and AIDS in the workplace. J Occup Med 1988;30(4):321-7 (ADAI rp 03140).

  184. Power R, Hartnoll R, Daviaud E. Drug injecting, AIDS, and risk behaviour: potential for change and intervention strategies. Br J Addict 1988 Jun;83(6):649-54 (ADAI jl).

  185. Power R, Jones S, Kearns G, Ward J, Perera J. Drug user networks, coping strategies, and HIV prevention in the community. J Drug Issues 1995;25(3):565-581 (ADAI jl).

  186. Rawson RA, Shoptaw S, Simmons J. Chemical dependency treatment and HIV disease: a challenge for the addictions field. Addict Recovery 1993;13(1):13-15 (ADAI jl).

  187. Ray S, Jones A, Shorty VJ, Bouie J, Wise G, Ratcliff S. Pretest effects of the AIA among treatment and nontreatment populations. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 138-63 (ADAI bk) Call No: RA 644 A25 C36 1991.

  188. Rezza G, Salmaso S, Abeni D, Brancato G, Anemona A, Rovetta C, Verani P, Perucci CA, Carballo M, Italian, WHO Working Group. HIV prevalence and frequency of risk behavior in injecting drug users entering treatment and out of treatment: A cross-sectional study in five Italian cities. J Drug Issues 1994;24(3):527-535 (ADAI jl).

  189. Rhodes F, Humfleet GL. Using goal-oriented counseling and peer support to reduce HIV/AIDS risk among drug users not in treatment. Drugs Society 1993;7(3/4):185-204 (ADAI jl).

  190. Rhodes F, Wolitski RJ, Thornton-Johnson S. An experiential program to reduce AIDS risk among female sex partners of injection-drug users. Health Soc Work 1992;17(4):261-272 (ADAI rp 05869).

  191. Rhodes T, Holland J. Outreach as a strategy for HIV prevention: Aims and practice. Health Educ Res 1994;7(4):533-546 (ADAI rp 06607).

  192. Rhodes TJ, Donoghoe MC, Hunter GM, Stimson GV. Continued risk behaviour among HIV positive drug injectors in London: implications for intervention. Addiction 1993 Nov;88(11):1553-60 (ADAI jl).

  193. Rico LE. Where to get help or information. In: Sorensen JL ; Wermuth LA ; Gibson DR ; Choi KH ; Guydish JR ; Batki SL (eds.) PREVENTING AIDS IN DRUG USERS AND THEIR SEXUAL PARTNERS. New York : Guilford Press, 1991, pp. 202-11. (ADAI bk) Call No: RA 644 A25 P753 1991.

  194. Rivers JE. Substance abuse and HIV among criminal justice populations: Overview from a program evaluation perspective. In: Inciardi JA (ed.) DRUG TREATMENT AND CRIMINAL JUSTICE. Newbury Park : SAGE, 1993, pp.228-246. (ADAI bk) Call No: HV 8836.5 D79 1993.

  195. Roberts D. Child welfare services for drug-exposed and HIV-affected newborns and their families. In: Barth RP ; Pietrzak J ; Ramler M (eds.) FAMILIES LIVING WITH DRUGS AND HIV; INTERVENTION AND TREATMENT STRATEGIES. New York : Guilford Press, 1993, pp.253-271 (ADAI bk) Call No: RJ 387 A25 F36 1993.

  196. Robles RR, Cancel LI, Colon HM, Matos TD, Freeman DH, Sahai, H. Prospective effects of perceived risk of developing HIV/AIDS on risk behaviors among injection drug users in Puerto Rico. Addiction 1995 Aug;90(8):1105-11 (ADAI jl).

  197. Ross MW, Stowe A, Wodak A, Miller ME, Gold J. A comparison of drug use and HIV infection risk behavior between injecting drug users currently in treatment, previously in treatment, and never in treatment. J Acquired Immune Defic Syn 1993;6:518-528 (ADAI rp 06066).

  198. Rouahi N, Levallois C, Favier F, Balmes JL, Mani JC. Flow cytometric analysis of oxidative product formation in phytohemagglutinin-stimulated ethanol-treated immune mononuclear cells. Drug Alcohol Depend 1989 Jan;23(1):55-62 (ADAI jl).

  199. Sawyer RC, Brown LS Jr, Bailey J, Hickson M, Lee P, McNair D, Rawls J, Skinner A. Drug abuse treatment programs as centers for HIV-related research and treatment. J Addict Dis 1993;12(4):121-9 (ADAI jl).

  200. Scheidt DM, Windle M. The alcoholics in treatment HIV risk (ATRISK) study: gender, ethnic and geographic group comparisons. J Stud Alcohol 1995 May;56(3):300-8 (ADAI jl).

  201. Schensul JJ, Weeks M. Ethnographic evaluation of AIDS-prevention programs. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 110-20 (ADAI bk) Call No: RA 644 A25 C36 1991.

  202. Schilling RF, El-Bassel N, Serrano Y, Wallace BC. AIDS prevention strategies for ethnic-racial minority substance users. Psychol Addict Behav 1992;6(2):81-90 (ADAI jl).

  203. Schneider M. Diagnosing and treating drug addiction in the AIDS/ARC victim (workshop). In: Korcok M (ed.) KEEPING HOPE ALIVE: PROCEEDINGS OF THE AMERICAN MEDICAL SOCIETY ON ALCOHOLISM AND OTHER DRUG DEPENDENCIES FORUM ON AIDS AND CHEMICAL DEPENDENCY. Providence, RI : Manisses Communications Group, 1988, pp. 58-61. (ADAI bk) Call No: RA 644 A25 K33 1988.

  204. Selwyn PA. Sterile needles and the epidemic of acquired immunodeficiency syndrome: issues for drug abuse treatment and public health. Adv Alcohol Subst Abuse 1987;7(2):99-105 (ADAI jl).

  205. Selwyn PA. Medical aspects of human immunodeficiency virus infection and its treatment in injecting drug users. In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK. (2nd edition) Baltimore : Williams & Wilkins, 1992. pp.744-774 (ADAI bk) Call No: RC 564 S826 1992.

  206. Selwyn PA, Hartel D, Wasserman W, Drucker E. Impact of the AIDS empidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989;79:1358-62 (ADAI rp 03848).

  207. Serfaty A, Brodin M, Lombrail P. A comparison of HIV-preventive strategies and legal sanctions against drug use in the European Union. Eur Addict Res 1995;1(3):115-120 (ADAI jl).

  208. Sibthorpe B, Lear B. Circumstances surrounding needle use transitions among injection drug users: implications for HIV intervention. Int J Addict 1994 Aug;29(10):1245-57 (ADAI jl).

  209. Siddiqui NS, Brown LS Jr, Meyer TJ, Gonzalez V. Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City. J Psychoactive Drugs 1993 Jul-Sep;25(3):245-50 (ADAI jl).

  210. Siegal HA, Carlson RG, Falck RS, Wang J. Drug abuse treatment experience and HIV risk behaviors among active drug injectors in Ohio. Am J Public Health 1995 Jan;85(1):105-8 (ADAI jl).

  211. Siegal HA, Falck RS, Carlson RG, Wang J. Reducing HIV needle risk behaviors among injection-drug users in the Midwest : An evaluation of the efficacy of standard and enhanced interventions. AIDS Educ Prev 1995;7(4):308-319 (ADAI rp 08169).

  212. Simpson DD, Camacho LM, Vogtsberger KN, Williams ML, Stephens RC, Jones A, Watson DD. Reducing AIDS risks through community outreach interventions for drug injectors. Psychol Addict Behav 1994;8(2):86-101 (ADAI jl).

  213. Simpson DD, Chatham LR, Joe GW. Cognitive enhancements to treatment in DATAR: Drug Abuse Treatment for AIDS Risks Reduction. In: Inciardi JA ; Tims FM ; Fletcher BW (eds.) INNOVATIVE APPROACHES IN THE TREATMENT OF DRUG ABUSE: PROGRAM MODELS AND STRATEGIES. Westport, CT : Greenwood Press, 1993, pp. 161-177 (ADAI bk) Call No: RC 564 I55 1993.

  214. Singer M. Needle access as an AIDS prevention strategy: a research perspective. Human Organization 1991;50(2):142-53 (ADAI rp 04908).

  215. Smereck GAD. Contact tracing for HIV infection: Policy and program implications from a 50-state survey. Drugs Society 1993;7(3/4):41-52 (ADAI jl).

  216. Sorensen JL. Preventing HIV transmission in drug treatment programs: what works? J Addict Dis 1991;10(4):67-79 (ADAI jl).

  217. Sorensen JL, Batki SL. Methadone maintenance as a setting for treating drug abusers with HIV infection. Psychol Addict Behav 1992;6(2):126-130 (ADAI jl).

  218. Sorensen JL, Batki SL, Good P, Wilkinson K. Methadone maintenance program for AIDS-affected opiate addicts. J Subst Abuse Treat 1989;6(2):87-94 (ADAI jl).

  219. Sorensen JL, Costantini MF, London JA. Coping with AIDS: strategies for patients and staff in drug abuse treatment programs. J Psychoactive Drugs 1989 Oct-Dec;21(4):435-40 (ADAI jl).

  220. Sorensen JL, Guydish JR. Adopting effective interventions. In: Sorensen JL ; Wermuth LA ; Gibson DR ; Choi KH ; Guydish JR ; Batki SL (eds.) PREVENTING AIDS IN DRUG USERS AND THEIR SEXUAL PARTNERS. New York : Guilford Press, 1991, pp. 153-67. (ADAI bk) Call No: RA 644 A25 P753 1991.

  221. Sorrell SJ, Springer ER. The argument against HIV-antibody testing in chemical dependence treatment programs. J Psychoactive Drugs 1989 Oct-Dec;21(4):419-21 (ADAI jl).

  222. Springer E. Effective AIDS prevention with active drug users: the harm reduction model. J Chem Depend Treat 1991;4(2):141-157 (ADAI jl).

  223. St. Lawrence JS, Jefferson KW, Banks PG, Cline TR, Alleyne E, Brasfield TL. Cognitive-behavioral group intervention to assist substance-dependent adolescents in lowering HIV infection risk. AIDS Educ Prev 1994;6(5):425-435 (ADAI rp 06763).

  224. Steer RA, Iguchi MY, Platt JJ. Hopelessness in i.v. drug users not in treatment and seeking HIV testing and counselling. Drug Alcohol Depend 1994 Jan;34(2):99-103 (ADAI jl).

  225. Stefanini GF, Mazzetti M, Zunarelli P, Piccinini G, Amorati P, Capelli S, Cicognani G, Gasbarrini G. In vivo effect of chronic ethanol abuse on membrane alpha 1-glycoprotein of lymphocytes and immune response to various stimulating agents. Alcoholism (NY) 1989 Jun;13(3):444-8 (ADAI jl).

  226. Stephens RC, Feucht TE, Roman SW. Effects of an intervention program on AIDS-related drug and needle behavior amoung intravenous drug users. Am J Public Health 1991;81(5):568-571 (ADAI rp 04796).

  227. Stephens RC, Simpson DD, Coyle SL, McCoy CB. Comparative effectiveness of NADR interventions. In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.519-556 (ADAI bk) Call No: RA 644 A25 H366 1993.

  228. Stevens SJ, Erickson JR, Estrada AL. Characteristics of female sexual partners of injection drug users in southern Arizona: Implications for effective HIV risk reduction interventions. Drugs Society 1993;7(3/4):129-142 (ADAI jl).

  229. Stimson GV. Editorial review : syringe-exchange programmes for injecting drug users. AIDS 1989;3:253-60 (ADAI rp 03895).

  230. Strom DP. AIDS and intravenous drug users: issues and treatment implications. In: Straussner SLA (ed.) CLINICAL WORK WITH SUBSTANCE-ABUSING CLIENTS. New York : Guilford Press, 1993, pp.330-350 (ADAI bk) Call No: RC 564 C57 1993.

  231. Tunis SL, Delucchi KL, Schwartz K, Banys P, Sees KL. The relationship of counselor and peer alliance to drug use and HIV risk behaviors in a six-month methadone detoxification program. Addict Behav 1995 May-Jun;20(3):395-405 (ADAI jl).

  232. Turner CF, Miller HG, Moses LE. Evaluating the effects of AIDS intervention. In: Turner CF ; Miller HG ; Moses LE (eds.) AIDS: SEXUAL BEHAVIOR AND INTRAVENOUS DRUG USE. Washington DC : National Academy Press, 1989, pp. 316-356. (ADAI bk) Call No: RA 644 A25 A435 1989.

  233. U.S. Public Health Service. THE PUBLIC HEALTH SERVICE STRATEGIC PLAN TO COMBAT HIV AND AIDS IN THE UNITED STATES. Washington DC : U.S. Department of Health and Human Services, 1992, iii, 52 p. (Books) Call No: RA 644 A25 S76 1992.

  234. Valdiserri RO, Gerber AR, Dillon BA, Campbell CH Jr. Clients without health insurance at publicly funded HIV counseling and testing sites: implications for early intervention. Public Health Rep 1995 Jan-Feb;110(1):47-52 (ADAI jl).

  235. van Ameijden EJ, van den Hoek AR, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994 Feb;84(2):275-81 (ADAI bk) Call No: RA 790.55 A53 1994.

  236. Vogtsberger KN, Desmond DP, Maddux JF. Problems in implementing an AIDS prevention program for injecting drug users. Am J Addict 1993;2(4):320-324 (ADAI jl).

  237. Wallace BC. Toward effective treatment models for special populations: criminal, pregnant, adolescent, uninsured, HIV-positive, methadone-maintained, and homeless populations. In: Wallace BC (ed.) THE CHEMICALLY DEPENDENT; PHASES OF TREATMENT AND RECOVERY. New York : Brunner/Mazel, 1992. pp. 310-336 (ADAI bk) Call No: RC 564 C478 1992.

  238. Ward J, Darke S, Hall W, Mattick R. Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research. Br J Addict 1992 Mar;87(3):447-53 (ADAI jl).

  239. Watkins KE, Metzger D, Woody G, McLellan AT. High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection. Am J Drug Alcohol Abuse 1992;18(4):389-98 (ADAI jl).

  240. Watson DD. Codependents: AIDS intervention and drug abuse treatment. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 327-8 (ADAI bk) Call No: RA 644 A25 C36 1991.

  241. Watters JK, Cheng YT. Toward comprehensive studies of HIV in intravenous drug users: issues in treatment-based and street-based samples. NIDA Res Monogr 1991;109:63-73 (ADAI bk) Call No: RA 644 A25 L65 1991.

  242. Wayment HA, Newcomb MD, Hannemann VL. Female and male intravenous drug users not-in-treatment: are they at differential risk for AIDS? Sex Roles 1993;28(1/2):111-125 (ADAI rp 05954).

  243. Weddington WW, et al. Risk behaviors for HIV transmission among intravenous-drug users not in drug treatment - United States, 1987-1989. MMWR 1990;39(16):273-276 (ADAI rp 05278).

  244. Weddington WW Jr, Brown BS. Acceptance of HIV-antibody testing by persons seeking outpatient treatment for cocaine abuse. J Subst Abuse Treat 1988;5(3):145-9 (ADAI jl).

  245. Weddington WW, Haertzen CA, Hess JM, Brown BS. Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study. Am J Drug Alcohol Abuse 1991 Sep;17(3):355-68 (ADAI jl).

  246. Weddington WW, Haertzen CA, Hess JM, Brown BS. Psychological reactions and retention by cocaine addicts during treatment according to HIV serostatus: a matched-control study. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 380-2 (ADAI bk) Call No: RA 644 A25 C36 1991.

  247. Weinstein MC, Graham JD, Siegel JE, Fineberg HV. Cost-effectiveness analysis of AIDS prevention programs : concepts, complications and illustrations. In: Turner CF ; Miller HG ; Moses LE (eds.) AIDS: SEXUAL BEHAVIOR AND INTRAVENOUS DRUG USE. Washington DC : National Academy Press, 1989, pp. 471-99. (ADAI bk) Call No: RA 644 A25 A435 1989.

  248. Weiss CJ. Working with chemically dependent HIV infected patients on an inpatient medical unit. J Chem Depend Treat 1991;4(2):45-53 (ADAI jl).

  249. Wells DV, Jackson JF. HIV and chemically dependent women: recommendations for appropriate health care and drug treatment services. Int J Addict 1992 May;27(5):571-85 (ADAI jl).

  250. Wiebel W. THE INDIGENOUS LEADER OUTREACH MODEL: INTERVENTION MANUAL. Rockville : National Institute on Drug Abuse, 1993, iv, 85 p., appendices. (Books) Call No: RA 644 A25 W43 1993.

  251. Wiebel WW. Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. NIDA Res Monogr Ser 1988;80:137-50 (ADAI bk) Call No: RA 644 A25 N44 1988.

  252. Wiebel WW, Biernacki P, Mulia N, Levin L. Outreach to IDUs not in treatment. In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.437-444 (ADAI bk) Call No: RA 644 A25 H366 1993.

  253. Williams AB, McNelly EA, WIlliams AE, D'Aquila RT. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. Aids Care 1992;4(1):35-41 (ADAI rp 05290).

  254. Williams ML, Snyder FR. Drug use, sexual behaviors, risk of HIV infection, and age differences among injection drug users not in treatment. In: Brown BS ; Beschner GM (eds.) HANDBOOK ON RISK OF AIDS: INJECTION DRUG USERS AND SEXUAL PARTNERS. Westport CT : Greenwood Press, 1993, pp.297-312 (ADAI bk) Call No: RA 644 A25 H366 1993.

  255. Wodak A, Des Jarlais DC. Strategies for the prevention of HIV infection among and from injecting drug users. Bull Narc 1993;45(1):47-60 (ADAI jl).

  256. Woodruff G, Sterzin ED. Family support services for drug- and AIDS-affected families. In: Barth RP ; Pietrzak J ; Ramler M (eds.) FAMILIES LIVING WITH DRUGS AND HIV; INTERVENTION AND TREATMENT STRATEGIES. New York : Guilford Press, 1993, pp.219-237 (ADAI bk) Call No: RJ 387 A25 F36 1993.

  257. Yankovich D, Archuleta E, Simental S. A mobile outreach program to intravenous drug users and female sexual partners in Long Beach, California. National Institute on Drug Abuse. COMMUNITY-BASED AIDS PREVENTION; STUDIES OF INTRAVENOUS DRUG USERS AND THEIR SEXUAL PARTNERS. (Proceedings of the First Annual NADR National Meeting.) Rockville : NIDA, 1991, pp. 26-9 (ADAI bk) Call No: RA 644 A25 C36 1991.

  258. Zakrzewski PA. Short term group work with intravenous drug using people with AIDS in a hospital setting. J Chem Depend Treat 1991;4(2):55-65 (ADAI jl).

[ Top ] [Bibliography List ] [ Library Home ]

http://depts.washington.edu/adai/lib/bibs/ad_120.htm